Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - Epilepsy and Epileptogenesis

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis
NINDS encourages grant applications for the Cooperative Program in Translational Research for resistant epilepsy and epileptogenesis.

Epilepsy, one of the most common neurological disorders affecting both American and international populations, is a significant public health burden. For some seizures can be controlled by available therapies; however, for others difficult side effects and conditions continue to affect quality of life. This announcement supports milestone-driven projects focusing on the preclinical development of new therapies to cure epilepsy, prevent the emergence of epilepsy following brain injury or in other high-risk groups, or to better treat individuals with intractable epilepsy.

Potential applicants should contact Dr. Randall Stewart, program director, Channels, Synapses and Circuits Cluster, NINDS, at 301-496-1917 or rs416y@nih.gov. For more information visit http://grants.nih.gov/grants/ guide/pa-files/PAR-10-144.html.

EUREKA in the Epilepsies
NINDS requests applications for exceptional, unconventional research enabling knowledge acceleration (EUREKA) in the epilepsies.

Epilepsy is one of the most common neurological disorders affecting both American and international populations. It involves disruption of basic neurobiological functions at all levels, including cellular/molecular biology and genetics, cognitive/behavioral and systems neuroscience, neuroplasticity, and neurodevelopment. This funding opportunity supports research to test novel, unconventional hypotheses or pursue major methodological or technical challenges. The potential impact of the proposed research on the epilepsy community must be substantial.

Letters of Intent Due Date: July 13, 2010

Application Due Date: August 13, 2010

Potential applicants should contact Dr. Brandy Fureman, program director, Channels, Synapses and Circuits Cluster, NINDS, at 301-496-1917 or furemanb@mail.nih.gov; or Dr. Randall Stewart, program director, Channels, Synapses and Circuits Cluster, NINDS, at 301496-1917 or rs416y@nih.gov. For more information visit http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-11-003.html.

Exploratory/Developmental Projects in Translational Research for Resistant Epilepsy and Epileptogenesis
NINDS invites grant applications for exploratory or developmental projects in translational research for resistant epilepsy and epileptogenesis.

Epilepsy is one of the most common neurological disorders and is a significant public health burden. Seizures can be controlled by available therapies for about two-thirds of people with epilepsy, but difficult side effects and conditions continue to affect quality of life for many. NINDS recognizes the need to encourage innovative research approaches to move toward real cures for epilepsy—defined as “no seizures, no side effects, and prevention in those at risk.” This announcement encourages projects that will complete preliminary steps for the pre-clinical development of therapeutics.

Potential applicants should contact Dr. Randall Stewart, program director, Channels, Synapses and Circuits Cluster, NINDS, at 301-496-1917 or rs416y@nih.gov. For more information visit http://grants.nih.gov/grants/ guide/pa-files/PAR-10-143.html.